OBJECTIVE: Radiosurgery is generally effective in obliterating true ar
teriovenous malformations, but less is known about its effects on angi
ographically occult vascular malformations (AOVMs). Since July 1983, 5
7 patients with surgically inaccessible AOVMs of the brain were treate
d using helium ion (47 patients) or linear accelerator (10 patients) r
adiosurgery. This study retrospectively evaluates the response of thes
e AOVMs to treatment. METHODS: All patients presented with previous he
morrhage. The mean patient age was 35.6 years (range, 13-71 yr). The m
ean AOVM volume was 2.25 cm(3) (range, 0.080-15.2 cm(3)), treated with
a mean of 18.0 Gy equivalent (physical dose x relative biological eff
ectiveness, which is 1.3 for helium ion Bragg peak) (range, 7.0-40 Gy
equivalent). The Drake scale scores before treatment were as follows:
excellent (25 patients), good (26 patients), and poor (6 patients). Th
e mean follow-up period was 7.5 years (range, 9 mo-13.8 yr). RESULTS:
Eighteen patients (32%) bled symptomatically (20 hemorrhages) after ra
diosurgery. Sixteen hemorrhages occurred within 36 months after radios
urgery (9.4% annual bleed rate; 16 hemorrhages/171 patient yr); 4 hemo
rrhages occurred more than 36 months after treatment (1.6% annual blee
d rate; 4 hemorrhages/257 patient yr) (P < 0.001). Complications inclu
ded symptomatic radiation edema (four patients, 7%), necrosis (one pat
ient, 2%), and increased seizure frequency (one patient, 2%). Eight pa
tients underwent surgical resection of their AOVMs 8 to 59 months afte
r radiosurgery because of subsequent hemorrhage. The Drake scale score
s after treatment were as follows: excellent (25 patients), good (24 p
atients), poor (3 patients), and dead (5 patients, 3 of whom died as a
result of causes unrelated to the AOVMs or radiosurgery). CONCLUSION:
Radiosurgery may be useful for AOVMs located in surgically inaccessib
le regions of the brain. A significant decrease in bleed rate exists m
ore than 3 years after treatment compared with the bleed rate within 3
years of treatment. Because current neuroradiological techniques are
not able to image obliterative response in these slow-flow vascular le
sions, longer term clinical follow-up is required.